Key Takeaways
- The Australian Commonwealth has filed a $2 billion lawsuit against 3M and 3M Australia over PFAS‑containing firefighting foam that contaminated 28 Defence Force bases.
- The claim alleges that 3M withheld internal test results showing significant adverse environmental effects of its PFAS products.
- PFAS (“forever chemicals”) are persistent, bio‑accumulative substances linked to health issues such as high cholesterol, low birth weight, and increased cancer risk.
- Previous settlements related to PFAS contamination have cost the government over $1 billion in remediation and $132 million in a class‑action payout to about 30,000 claimants.
- A Senate inquiry into PFAS made 47 recommendations, including pursuing legal action to fund site remediation and providing subsidised blood testing, health screening, and mental‑health support for affected communities.
- Although 3M states it never manufactured PFAS in Australia and stopped selling the foams two decades ago, the Defence Department continued using the foam until 2012, extending exposure.
Background of the Legal Action
The Commonwealth’s lawsuit marks the largest ever legal claim brought by the Australian federal government. Attorney‑General Michelle Rowland announced that the government seeks to recover the “significant costs” incurred from investigating, managing, and remediating PFAS contamination stemming from legacy use at Defence sites. According to Rowland, the contamination has already cost Defence and taxpayers over $1 billion to date, covering investigation, remediation, and mitigation efforts. The government frames the suit as a stand against a major multinational corporation, signalling willingness to pursue accountability despite the scale of the defendant.
Allegations Against 3M
The core allegation is that 3M withheld the results of its own environmental laboratory testing, which demonstrated substantial adverse environmental effects associated with its PFAS‑based firefighting foams. By allegedly concealing this data, 3M is said to have prevented regulators and users from fully understanding the risks, thereby contributing to widespread contamination. The lawsuit contends that this misconduct directly led to the extensive PFAS pollution now evident at 28 Defence bases across the country, necessitating costly cleanup operations.
What Are PFAS and Why They Matter
PFAS (per‑ and poly‑fluoroalkyl substances) are a group of synthetic chemicals valued for their water‑proof, non‑stick, and stain‑resistant properties. They are found in products ranging from firefighting foam and cosmetics to non‑stick cookware. Their defining characteristic is extreme persistence in the environment; they do not break down readily, can accumulate in living organisms, and have been detected in the blood of humans and wildlife worldwide. Scientific studies have linked PFAS exposure to a range of health concerns, including elevated cholesterol levels, reduced fetal growth, and heightened risks of testicular and kidney cancers.
Historical Use of PFAS‑Containing Foam in Australia
Aqueous film‑forming foams (AFFF) containing PFAS were employed by the Australian Defence Force from the 1970s onward. Although 3M announced a phase‑out of the foam in May 2000 and U.S. authorities warned the Australian government that same day about potential health risks, the Department of Defence did not fully replace the 3M product until July 2012. This delay meant that PFAS‑laden foam remained in service for nearly two decades after the initial warnings, exacerbating contamination at bases such as RAAF Wagga Wagga and numerous other sites.
Previous PFAS Settlements and Compensation
Before the current $2 billion claim, the government had already addressed PFAS fallout through other legal channels. In 2023, a class action over PFAS contamination from firefighting foam at seven Defence sites resulted in a $132 million payout to roughly 30,000 claimants who alleged groundwater exposure. Earlier settlements for property‑value loss and distress in Katherine (NT), Oakey (Qld), and Williamtown (NSW) totalled $212 million. Additionally, 3M settled a $10.3 billion (US) claim with American public water providers in 2023, though it admitted no liability. These precedents underscore the financial and health burdens PFAS imposes on communities and governments alike.
Health and Environmental Impacts Highlighted by Experts
Experts consulted by ABC News explained that PFAS leaches into water systems, leading to widespread detection in human and animal blood. Exposure has been correlated with higher cholesterol, lower birth weights in infants, and increased incidence of testicular and kidney cancer. The chemicals’ persistence means that remediation is complex and costly, often requiring long‑term monitoring and treatment of contaminated water supplies. Communities near former Defence bases, such as Williamtown, continue to grapple with the legacy of PFAS pollution, prompting calls for ongoing health surveillance and support.
Senate Inquiry Recommendations
A recent Senate inquiry into the extent, regulation, and management of PFAS in Australia delivered 47 recommendations. Chair Senator Lidia Thorpe emphasized that any funds recovered from legal action must be dedicated to remediation and addressing future environmental and community impacts, rather than merely bolstering the budget. The inquiry criticised the government’s decision not to pursue damages for health impacts as “deeply concerning.” Key recommendations included providing subsidised PFAS blood testing, enhanced cancer and health screening, and targeted mental‑health support for individuals with the highest exposure levels.
Implications for Future Policy and Remediation
If successful, the Commonwealth’s $2 billion claim could furnish a substantial financial resource for cleaning up contaminated Defence sites and supporting affected populations. The outcome may also set a precedent for holding multinational corporations accountable for environmental harms linked to their products. Beyond compensation, the case reinforces the need for stricter regulation of PFAS, faster adoption of safer alternatives, and comprehensive health‑monitoring programmes for communities historically exposed to these “forever chemicals.” The ongoing legal battle thus represents both a financial reckoning and a catalyst for broader public‑health and environmental safeguards.